Home › Ariad shares fall as it cuts revenue guidance
 

Keywords :   


Ariad shares fall as it cuts revenue guidance

2015-12-12 15:42:31| Biotech - Topix.net

Shares of Ariad Pharmaceuticals fell Friday after it cut revenue guidance as it continues to negotiate with French regulators over the price of its leukemia treatment, Iclusig. The Cambridge, Massachusetts-based developer of cancer treatments said that it previously expected to reach an agreement by the end of the year, but it now expects negotiations to continue into 2016.

Tags: fall revenue shares guidance

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
01.07Union expected to call off Port Talbot strike action
01.07Mentorship in Motion
01.07Farm Progress America, July 1, 2024
01.07Hurricane Beryl Forecast Discussion Number 11
01.07Hurricane Beryl Graphics
01.07Hurricane Beryl Wind Speed Probabilities Number 11
01.07Hurricane Beryl Forecast Advisory Number 11
01.07Hurricane Beryl Public Advisory Number 11
More »